Challenges of Serving Low-income Medicare Beneficiaries: Impact of Cost Sharing Cindy Parks Thomas Brandeis University Schneider Institute for Health Policy.

Slides:

Advertisements

Similar presentations

Dual Eligible and Low-Income Medicare Beneficiaries and Part D Presentation to National Medicaid Congress by Andy Schneider, Senior Advisor June 5, 2006.

Advertisements

Part Ds Low-Income Benefits: Theory and Reality Marc Steinberg, Families USA Health Action 2006 January 26, 2006 ** Washington, DC

K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Figure 0 The Transition of Dual Eligibles to Medicare Drug Coverage: Implications for Beneficiaries.

1 Filling the Holes in Part D: SPAPs to the Rescue? Marc Steinberg, Families USA Health Action 2005 * January 27,

DataBrief: Did you know… DataBrief Series ● February 2011 ● No. 12 Dual Eligibles Across the States In 2008, dual eligibles as a percent of the total Medicare.

Reduction of Medicaid Expenditures from State Prescription Programs in Illinois and Wisconsin Donald S Shepard, PhD* Desiree Koh, * Cindy Thomas, PhD*

Y0096_MRK_OK_PDSALPRE15 APPROVED bcbsok.com Your presenter today: Bob Archer Health Insurance Enrollment Center.

2006 Retiree MIP Overview October 2006 Rajiv Nundy & Kent Humphries HR Compensation Management.

Supplementing PACE through Medicare Part D

Pharmaceutical Assistance Contract for the Elderly (PACE) Program began July 1, 1984 PACE Needs Enhancement Tier (PACENET) Program began January 1, 1997.

Ideas for People Losing Illinois Cares Rx Benefits July 2011.

Medicare Part D and HIV/AIDS: What a Clinician May Want to Know Laura Cheever, M.D., ScM Deputy Director, Chief Medical Officer HIV/AIDS Bureau Health.

THE AIDS INSTITUTE The AIDS Institute HEALTH REFORM AND ADAP Emily McCloskey, Public Policy Associate Carl Schmid, Deputy Executive Director AIDS Drug.

MEDICARE: PAST, PRESENT AND F UTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.

Deciphering Medicare Part D Susan Miller, Patient Education Douglas A. Magenheim, MD, MBA, FACP.

© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health? Get Educated, Get Enrolled An.

Medicare and the New Prescription Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser.

Medicare Modernization Act, Part D Prescription Drug Benefit Presentation for County Program Administrators September 1, 2005.

Joint Informational Hearing The Federal Medicare Prescription Drug Act: State Readiness, Implementation, and Consumer Issues Bonnie Burns, Training and.

Agenda Trends in the Senior Market Part D Benefits & Guidelines

MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.

1 State Perspectives on Medicare Part D: Lessons from Pharmacy Plus Programs Cindy Parks Thomas Donald Shepard Christine E. Bishop Daniel M. Gilden Brandeis.

© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?

Patient Advocacy. Access, Affordability, and understanding treatment costs.

Medicare Prescription Drug Benefit: Part D Health & Disability Advocates Stephanie Altman, J.D Ext

Jeffrey Levi, Ph.D. American Public Health Association Annual Meeting November 8, 2004 Options for enhancing quality and equity in the CARE Act: If not.

1 Medicare Prescription Drug Improvement and Modernization Act & Beneficiaries With Mental Illnesses Presentation to NAMI Convention June 19, 2005 Andrew.

Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Roy Trudel, CMSO National Eligibility Workers Association 07/12/05.

MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy.

Slide -1 Medicare Prescription Drug Benefit Denise S. Stanley, Pharm.D. Atlanta Regional Office Centers for Medicare & Medicaid Services March 17, 2006.

January National Medicare & You Training Program Amy Larrick, CMS NAACP April 27, 2006.

NOTES: Numbers may not sum to total due to rounding. People with disabilities under age 65 were not eligible for Medicare prior to SOURCE: Centers.

UllmanView Graph # 1 OVERVIEW Background and Basics of Cost-Sharing Designing Premiums Analysis of Impacts of Four States’ Premium Policies Implications.

Medicare and Patient Assistance Sean M. Dougherty Senior Director Medicare Strategy & Patient Assistance Programs Government, Public Policy And Managed.

 The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27,

Medicare Part D Symposium Thursday, September 1, 2005 Sacramento, CA Cathy Senderling Senior Legislative Advocate, CWDA.

The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.

THE COMMONWEALTH FUND Medicare Part D: What Are The Concerns? Stuart Guterman Director, Program on Medicare’s Future The Commonwealth Fund Association.

11/8/051 Medicare Prescription Drug Benefits Employee Workshop November 2005.

0 Beneficiary Choices in Medicare Part D and Plan Features in 2006 Supported by PhRMA September 13, 2006.

Avalere Health LLC | The intersection of business strategy and public policy The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries.

Medicare Savings Due to Prescription Drug Coverage for Near-poor Elders Christine Bishop, Ph.D. 1 Andrew Ryan, M.A. 1 Daniel Gilden, M.S. 2 Cindy Parks.

Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.

K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Figure 0 Medicare Modernization Act of 2003: Implications for Low-Income People and State.

"Helping Seniors Make Smart Decisions about their Drug Coverage Options" Hal Prink, FHFMA, Medicare Patient Advocate, Senior’s Voice for Healthcare Rights.

Avalere Health LLC | The intersection of business strategy and public policy The Medicare Modernization Act: The Impact on States and Low-Income Beneficiaries.

Figure 1 K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Dual Eligibles: The Basics Barbara Lyons, Ph.D. Director, Kaiser Commission on.

1 Cost Sharing for Low-Income Beneficiaries and Supplementing Part D Examples from Pharmacy Plus Medicaid Demonstration Programs Summit for State Health.

1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.

Karissa A. Laur Director, Prescription Assistance Programs Coordinating Patient Assistance Programs with Medicare Part D: A Manufacturer’s Perspective.

Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Deirdre Duzor Director, Pharmacy Division Centers for Medicare & Medicaid Services.

1 State Options for Supplementing Medicare Part D Drug Coverage Invitational Summit on Medicare Part D Implementation Issues Jack Hoadley Georgetown University.

Chapter 7: Medicare Part D Prescription Drug Coverage in Patients with Chronic Kidney Disease 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D.

Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.

Estimating the Cost of the Medicare Drug Benefit Philip Ellis Steve Lieberman Medicare Prescription Drug Congress February 27, 2004.

National Conference of State Legislatures National Medicaid Congress June 5, 2006 State Pharmaceutical Assistance Programs, Medicaid & Part D: 2006 State.

Special Needs Plans Sandra Bastinelli, MS, RN Acting Director, Division of Special Programs Medicare Advantage Group Center for Beneficiary Choices.

Avalere Health LLC | The intersection of business strategy and public policy The Impact of Enrollment in the Medicare Prescription Drug Benefit on Premiums.

State Responses to Medicare Part D Presented by: Kimberley Fox, Senior Policy Analyst, Institute for Health Policy Academy Health Annual Research Meeting.

Overview of the Medicare Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser Family.

Medicare Enrollment, NOTES: Numbers may not sum to total due to rounding. People with disabilities under age 65 were not eligible for Medicare.

For a middle-age person, before tax credits, premiums for comparable coverage would be similar under each plan Annual individual market premium for a silver.

2018 Medicare Prescription Drug Benefit

Director, Pennsylvania PACE Program National Medicare Congress

Medicare Enrollment, NOTES: Numbers may not sum to total due to rounding. People with disabilities under age 65 were not eligible for Medicare.

Cost Sharing Under Part D: Impact on Beneficiaries with the Standard Benefit Bruce Stuart, PhD Director, Peter Lamy Center on Drug Therapy and Aging.

Presented by Tricia Neuman, Sc.D.

Medicare Reform: Implications for Pharmaceutical Manufacturers

SeniorCare Prescription drug coverage for Wisconsin residents age 65+

Presentation transcript:

Challenges of Serving Low-income Medicare Beneficiaries: Impact of Cost Sharing Cindy Parks Thomas Brandeis University Schneider Institute for Health Policy Presentation to National Academy of Social Insurance Annual Meeting January 2005

2 2 Medicare Part D Low-income Subsidies Provide Considerable Assistance Income and Asset Eligibility Requirements Benefit Medicare Full Dual EligiblesNo premiums or coinsurance Copays $1/$3 <100% FPL Copays $2/$5 >100% FPL Income up to 135% FPL Assets <$6,000 single /$9,000 couple No premiums or coinsurance Copays $2, $5 up to limit Income % FPL Assets <$10,000single/ $20,000 couple Premium sliding scale Deductible $50 Cost sharing 15% to catastrophic, $2/$5 after limit Standard benefitPremium, deductible, cost sharing, and gap until limit

3 3 Part D Low-income Subsidies Are A Valuable but Limited Safety Net Source: U.S. Congressional Budget Office, July million eligible 6 million not eligible

4 4 Why the Low-income Subsidy is Critical Source: Actuarial Research Corporation and Kaiser Family Foundation, November 2004 Estimated average out of pocket costs under MMA, 2006

5 5 MMA and Low-income Beneficiaries: Medicare/Medicaid Dual Eligibles 6.3 Million dual eligibles move from state Medicaid programs to private drug plans :  Autoenrollment approved  Use of formularies  Copayments for dispensing  Appeals process differs  Changes in disease management – issues with coordination

6 6 MMA and Low-Income Beneficiaries: Non- Dual Eligibles Additional 3-5 million non/Medicaid low-income beneficiaries may receive subsidies  Must enroll Other low-income beneficiaries will not receive subsidies 1.5 million now have pharmacy coverage through state pharmacy assistance programs (SPAPs) but most will not be eligible for subsidy  Eligibility averages 222% FPL (most states above 150% FPL)  SPAP asset test uncommon  Most SPAP benefits more generous than MMA Source: Rutgers CSHP, 2004

7 7 States are Considering Options to Supplement Part D Coverage SPAP wraparound coverage will count toward true out of pocket costs (TrOOP) toward catastrophic States may cover  Premiums, deductibles, copays or gaps  Non-formulary/ out of network meds States may also contract out to prescription drug plans for wrap around coverage  May co-brand and market with preferred plans States may choose not to provide supplemental coverage

8 8 Estimating the Impact of Prescription Cost Sharing for Low-income Seniors Brandeis/JEN Evaluation of the Impact of Pharmacy Plus Waivers in Illinois and Wisconsin (CMS /TO2) Analysis of cost sharing and plan design strategies in two waiver states (RWJ HCFO ) Looks specifically at non-Medicaid, age 65+, incomes up to 200% FPL Impact of insurance plan design on Medicare beneficiaries – enrollment and spending

9 9 What is the Effect of Filling in Gaps in Coverage for Low-income Seniors? We measure the impact of small (and large) differences in cost sharing  None vs. $1/$4 vs. $5/$15  First dollar vs. $500 deductible  “Soft cap” versus no benefit cap We assess the importance of the low-income subsidy, and design and cost of wrap around coverage

10 Prescription Drug Costs for Enrolled Populations Differ with Benefit Design and Income Note: Members enrolled full 12 months, program year 1, , before rebates. Member share Program + tpl share $1633$1499$1426 $1853$1731$1943 $1712 $1938

11 Low Income Enrollees Show Strong Response to Cost Sharing Illinois $1/$4 copayments, first dollar Wisconsin $5/$15 copayments/deductible FPL Mean Rxs Mean Rx Expenditures Percent Generic Mean Rxs Mean Rx Expenditures Percent Generic <100% 45.4$ %39.2$ % 100 – 135% 46.6$ %44.3$ % 135 – 150% 47.2$ %45.7$ % 150 – 200% 47.1$ %47.1$ % *Illinois enrollee sample and Wisconsin controls , matched for age, gender, race, income urban/rural, medical diagnoses and prior year Medicare Part A and B utilization Average expenditures and use for matched sample across states*

12 Lower use of prescriptions prior to meeting the deductible 23 percent fewer purchases during deductible period, compared to 7 percent for members of same program but not subject to deductible After deductible is met, greater use of medications, also related to income Indicates low income beneficiaries may not be able to pay full costs during the deductible (or in coverage gaps) Deductibles Limit the Number of Medications Purchased

13 More Generous Benefits Draw a Healthier Low-income Population Odds Ratios Enrollee Disease Prevalence Compared to Non-enrollees Illinois SC (more generous) (<200% FPL) Wisconsin SC (less generous) (<200% FPL) Wisconsin SC with Deductible (even less generous) ( % FPL) Heart Disease* CHF* Stroke* COPD * Significant difference across programs Source: JEN Associates analysis of SeniorCare program enrollees and Medicare Parts A and B 2002 claims

14 Implications for MMA The low income subsidy will be a critical factor for beneficiaries 1/3 with incomes below 200% FPL not eligible for Part D subsidy Even small differences in cost sharing affects this group Different response to deductibles and cost sharing than in higher income populations Additional access issues for the very poor (<100% FPL) More generous benefits encourage more widespread enrollment States supplemental benefits will be important to ensure access